Copyright Reports & Markets. All rights reserved.

COVID-19 Impact on Global Cell therapy Processing Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Cell therapy Processing Revenue
  • 1.4 Market Analysis by Type
    • 1.4.1 Global Cell therapy Processing Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Products
    • 1.4.3 Services
    • 1.4.4 Software
  • 1.5 Market by Application
    • 1.5.1 Global Cell therapy Processing Market Share by Application: 2020 VS 2026
    • 1.5.2 Cardiovascular Disease
    • 1.5.3 Bone Repair
    • 1.5.4 Neurological Disorders
    • 1.5.5 Skeletal Muscle RepairImmune Diseases
  • 1.6 Coronavirus Disease 2019 (Covid-19): Cell therapy Processing Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the Cell therapy Processing Industry
      • 1.6.1.1 Cell therapy Processing Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and Cell therapy Processing Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for Cell therapy Processing Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Global Growth Trends by Regions

  • 2.1 Cell therapy Processing Market Perspective (2015-2026)
  • 2.2 Cell therapy Processing Growth Trends by Regions
    • 2.2.1 Cell therapy Processing Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Cell therapy Processing Historic Market Share by Regions (2015-2020)
    • 2.2.3 Cell therapy Processing Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Cell therapy Processing Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Cell therapy Processing Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Cell therapy Processing Players by Market Size
    • 3.1.1 Global Top Cell therapy Processing Players by Revenue (2015-2020)
    • 3.1.2 Global Cell therapy Processing Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Cell therapy Processing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Cell therapy Processing Market Concentration Ratio
    • 3.2.1 Global Cell therapy Processing Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Cell therapy Processing Revenue in 2019
  • 3.3 Cell therapy Processing Key Players Head office and Area Served
  • 3.4 Key Players Cell therapy Processing Product Solution and Service
  • 3.5 Date of Enter into Cell therapy Processing Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global Cell therapy Processing Historic Market Size by Type (2015-2020)
  • 4.2 Global Cell therapy Processing Forecasted Market Size by Type (2021-2026)

5 Cell therapy Processing Breakdown Data by Application (2015-2026)

  • 5.1 Global Cell therapy Processing Market Size by Application (2015-2020)
  • 5.2 Global Cell therapy Processing Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Cell therapy Processing Market Size (2015-2020)
  • 6.2 Cell therapy Processing Key Players in North America (2019-2020)
  • 6.3 North America Cell therapy Processing Market Size by Type (2015-2020)
  • 6.4 North America Cell therapy Processing Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Cell therapy Processing Market Size (2015-2020)
  • 7.2 Cell therapy Processing Key Players in Europe (2019-2020)
  • 7.3 Europe Cell therapy Processing Market Size by Type (2015-2020)
  • 7.4 Europe Cell therapy Processing Market Size by Application (2015-2020)

8 China

  • 8.1 China Cell therapy Processing Market Size (2015-2020)
  • 8.2 Cell therapy Processing Key Players in China (2019-2020)
  • 8.3 China Cell therapy Processing Market Size by Type (2015-2020)
  • 8.4 China Cell therapy Processing Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Cell therapy Processing Market Size (2015-2020)
  • 9.2 Cell therapy Processing Key Players in Japan (2019-2020)
  • 9.3 Japan Cell therapy Processing Market Size by Type (2015-2020)
  • 9.4 Japan Cell therapy Processing Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Cell therapy Processing Market Size (2015-2020)
  • 10.2 Cell therapy Processing Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Cell therapy Processing Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Cell therapy Processing Market Size by Application (2015-2020)

11 India

  • 11.1 India Cell therapy Processing Market Size (2015-2020)
  • 11.2 Cell therapy Processing Key Players in India (2019-2020)
  • 11.3 India Cell therapy Processing Market Size by Type (2015-2020)
  • 11.4 India Cell therapy Processing Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Cell therapy Processing Market Size (2015-2020)
  • 12.2 Cell therapy Processing Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Cell therapy Processing Market Size by Type (2015-2020)
  • 12.4 Central & South America Cell therapy Processing Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Anthrogenesis Corp.
    • 13.1.1 Anthrogenesis Corp. Company Details
    • 13.1.2 Anthrogenesis Corp. Business Overview and Its Total Revenue
    • 13.1.3 Anthrogenesis Corp. Cell therapy Processing Introduction
    • 13.1.4 Anthrogenesis Corp. Revenue in Cell therapy Processing Business (2015-2020))
    • 13.1.5 Anthrogenesis Corp. Recent Development
  • 13.2 BioNTech
    • 13.2.1 BioNTech Company Details
    • 13.2.2 BioNTech Business Overview and Its Total Revenue
    • 13.2.3 BioNTech Cell therapy Processing Introduction
    • 13.2.4 BioNTech Revenue in Cell therapy Processing Business (2015-2020)
    • 13.2.5 BioNTech Recent Development
  • 13.3 Cell Ideas
    • 13.3.1 Cell Ideas Company Details
    • 13.3.2 Cell Ideas Business Overview and Its Total Revenue
    • 13.3.3 Cell Ideas Cell therapy Processing Introduction
    • 13.3.4 Cell Ideas Revenue in Cell therapy Processing Business (2015-2020)
    • 13.3.5 Cell Ideas Recent Development
  • 13.4 Epic Sciences
    • 13.4.1 Epic Sciences Company Details
    • 13.4.2 Epic Sciences Business Overview and Its Total Revenue
    • 13.4.3 Epic Sciences Cell therapy Processing Introduction
    • 13.4.4 Epic Sciences Revenue in Cell therapy Processing Business (2015-2020)
    • 13.4.5 Epic Sciences Recent Development
  • 13.5 Roche
    • 13.5.1 Roche Company Details
    • 13.5.2 Roche Business Overview and Its Total Revenue
    • 13.5.3 Roche Cell therapy Processing Introduction
    • 13.5.4 Roche Revenue in Cell therapy Processing Business (2015-2020)
    • 13.5.5 Roche Recent Development
  • 13.6 FuGENE
    • 13.6.1 FuGENE Company Details
    • 13.6.2 FuGENE Business Overview and Its Total Revenue
    • 13.6.3 FuGENE Cell therapy Processing Introduction
    • 13.6.4 FuGENE Revenue in Cell therapy Processing Business (2015-2020)
    • 13.6.5 FuGENE Recent Development
  • 13.7 IBC Pharmaceuticals Inc.
    • 13.7.1 IBC Pharmaceuticals Inc. Company Details
    • 13.7.2 IBC Pharmaceuticals Inc. Business Overview and Its Total Revenue
    • 13.7.3 IBC Pharmaceuticals Inc. Cell therapy Processing Introduction
    • 13.7.4 IBC Pharmaceuticals Inc. Revenue in Cell therapy Processing Business (2015-2020)
    • 13.7.5 IBC Pharmaceuticals Inc. Recent Development
  • 13.8 Bluebird Bio Inc.
    • 13.8.1 Bluebird Bio Inc. Company Details
    • 13.8.2 Bluebird Bio Inc. Business Overview and Its Total Revenue
    • 13.8.3 Bluebird Bio Inc. Cell therapy Processing Introduction
    • 13.8.4 Bluebird Bio Inc. Revenue in Cell therapy Processing Business (2015-2020)
    • 13.8.5 Bluebird Bio Inc. Recent Development
  • 13.9 Immodulon-Therapeutics
    • 13.9.1 Immodulon-Therapeutics Company Details
    • 13.9.2 Immodulon-Therapeutics Business Overview and Its Total Revenue
    • 13.9.3 Immodulon-Therapeutics Cell therapy Processing Introduction
    • 13.9.4 Immodulon-Therapeutics Revenue in Cell therapy Processing Business (2015-2020)
    • 13.9.5 Immodulon-Therapeutics Recent Development
  • 13.10 Immunomedics Inc.
    • 13.10.1 Immunomedics Inc. Company Details
    • 13.10.2 Immunomedics Inc. Business Overview and Its Total Revenue
    • 13.10.3 Immunomedics Inc. Cell therapy Processing Introduction
    • 13.10.4 Immunomedics Inc. Revenue in Cell therapy Processing Business (2015-2020)
    • 13.10.5 Immunomedics Inc. Recent Development
  • 13.11 Juno Therapeutics Inc.
    • 10.11.1 Juno Therapeutics Inc. Company Details
    • 10.11.2 Juno Therapeutics Inc. Business Overview and Its Total Revenue
    • 10.11.3 Juno Therapeutics Inc. Cell therapy Processing Introduction
    • 10.11.4 Juno Therapeutics Inc. Revenue in Cell therapy Processing Business (2015-2020)
    • 10.11.5 Juno Therapeutics Inc. Recent Development
  • 13.12 Medlmmune Inc.
    • 10.12.1 Medlmmune Inc. Company Details
    • 10.12.2 Medlmmune Inc. Business Overview and Its Total Revenue
    • 10.12.3 Medlmmune Inc. Cell therapy Processing Introduction
    • 10.12.4 Medlmmune Inc. Revenue in Cell therapy Processing Business (2015-2020)
    • 10.12.5 Medlmmune Inc. Recent Development
  • 13.13 NeoStem Oncology
    • 10.13.1 NeoStem Oncology Company Details
    • 10.13.2 NeoStem Oncology Business Overview and Its Total Revenue
    • 10.13.3 NeoStem Oncology Cell therapy Processing Introduction
    • 10.13.4 NeoStem Oncology Revenue in Cell therapy Processing Business (2015-2020)
    • 10.13.5 NeoStem Oncology Recent Development
  • 13.14 Neurotech USA
    • 10.14.1 Neurotech USA Company Details
    • 10.14.2 Neurotech USA Business Overview and Its Total Revenue
    • 10.14.3 Neurotech USA Cell therapy Processing Introduction
    • 10.14.4 Neurotech USA Revenue in Cell therapy Processing Business (2015-2020)
    • 10.14.5 Neurotech USA Recent Development
  • 13.15 Novartis
    • 10.15.1 Novartis Company Details
    • 10.15.2 Novartis Business Overview and Its Total Revenue
    • 10.15.3 Novartis Cell therapy Processing Introduction
    • 10.15.4 Novartis Revenue in Cell therapy Processing Business (2015-2020)
    • 10.15.5 Novartis Recent Development
  • 13.16 Persimmune Inc.
    • 10.16.1 Persimmune Inc. Company Details
    • 10.16.2 Persimmune Inc. Business Overview and Its Total Revenue
    • 10.16.3 Persimmune Inc. Cell therapy Processing Introduction
    • 10.16.4 Persimmune Inc. Revenue in Cell therapy Processing Business (2015-2020)
    • 10.16.5 Persimmune Inc. Recent Development
  • 13.17 Pluristem Therapeutics
    • 10.17.1 Pluristem Therapeutics Company Details
    • 10.17.2 Pluristem Therapeutics Business Overview and Its Total Revenue
    • 10.17.3 Pluristem Therapeutics Cell therapy Processing Introduction
    • 10.17.4 Pluristem Therapeutics Revenue in Cell therapy Processing Business (2015-2020)
    • 10.17.5 Pluristem Therapeutics Recent Development
  • 13.18 BioMed Valley Discoveries Inc.
    • 10.18.1 BioMed Valley Discoveries Inc. Company Details
    • 10.18.2 BioMed Valley Discoveries Inc. Business Overview and Its Total Revenue
    • 10.18.3 BioMed Valley Discoveries Inc. Cell therapy Processing Introduction
    • 10.18.4 BioMed Valley Discoveries Inc. Revenue in Cell therapy Processing Business (2015-2020)
    • 10.18.5 BioMed Valley Discoveries Inc. Recent Development
  • 13.19 Regeneron Pharmaceuticals Inc.
    • 10.19.1 Regeneron Pharmaceuticals Inc. Company Details
    • 10.19.2 Regeneron Pharmaceuticals Inc. Business Overview and Its Total Revenue
    • 10.19.3 Regeneron Pharmaceuticals Inc. Cell therapy Processing Introduction
    • 10.19.4 Regeneron Pharmaceuticals Inc. Revenue in Cell therapy Processing Business (2015-2020)
    • 10.19.5 Regeneron Pharmaceuticals Inc. Recent Development
  • 13.20 UCL Business PLC.
    • 10.20.1 UCL Business PLC. Company Details
    • 10.20.2 UCL Business PLC. Business Overview and Its Total Revenue
    • 10.20.3 UCL Business PLC. Cell therapy Processing Introduction
    • 10.20.4 UCL Business PLC. Revenue in Cell therapy Processing Business (2015-2020)
    • 10.20.5 UCL Business PLC. Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    This report focuses on the global Cell therapy Processing status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Cell therapy Processing development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

    The key players covered in this study
    Anthrogenesis Corp.
    BioNTech
    Cell Ideas
    Epic Sciences
    Roche
    FuGENE
    IBC Pharmaceuticals Inc.
    Bluebird Bio Inc.
    Immodulon-Therapeutics
    Immunomedics Inc.
    Juno Therapeutics Inc.
    Medlmmune Inc.
    NeoStem Oncology
    Neurotech USA
    Novartis
    Persimmune Inc.
    Pluristem Therapeutics
    BioMed Valley Discoveries Inc.
    Regeneron Pharmaceuticals Inc.
    UCL Business PLC.

    Market segment by Type, the product can be split into
    Products
    Services
    Software
    Market segment by Application, split into
    Cardiovascular Disease
    Bone Repair
    Neurological Disorders
    Skeletal Muscle RepairImmune Diseases

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    The study objectives of this report are:
    To analyze global Cell therapy Processing status, future forecast, growth opportunity, key market and key players.
    To present the Cell therapy Processing development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
    To strategically profile the key players and comprehensively analyze their development plan and strategies.
    To define, describe and forecast the market by type, market and key regions.

    In this study, the years considered to estimate the market size of Cell therapy Processing are as follows:
    History Year: 2015-2019
    Base Year: 2019
    Estimated Year: 2020
    Forecast Year 2020 to 2026
    For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

    Buy now